A finance director and two lawyers have been committed to stand trial on eight counts of insider dealing. Andrew King, FD of Neutec Pharma, a biopharmaceutical company, along with lawyers Michael McFall and Andrew Rimmington, have pleaded not guilty to the charges and were remanded on bail for trial next April. King was charged with disclosing information relating to the takeover of Neutec.
展开▼
机译：一名财务总监和两名律师已承诺对八项内幕交易进行审判。生物制药公司Neutec Pharma的FD Andrew Andrew King以及律师Michael McFall和Andrew Rimmington均对上述指控表示不认罪，并于明年4月被保释候审。金被控披露与收购Neutec有关的信息。
展开▼
